Faron, etusivu

releases and publications

Faron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Faron’s Financial Calendar for 2024

Regulatory

Phase 1 BEXMAB data presented at ASH

Regulatory

MATINS Trial in Cell Reports Medicine

Grant of options

Insider Transaction Regulatory

Faron Initiates Phase 2 Part of BEXMAB Study

Regulatory

Faron to present data from BEXMAB study at ASH

Regulatory

Managers’ transactions

Insider Transaction Regulatory

Exercise of options

Insider Transaction Regulatory

Results of Placing

Regulatory
PreviousNext
Back to top